• 1
    Roberts J, Lain K. Recent insights into the pathogenesis of preeclampsia. Placenta 2002; 23: 359372.
  • 2
    Maynard S, Min J, Merchan J et al . Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649658.
  • 3
    Zhou Y, McMaster M, Woo K et al . Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes and low platelets syndrome. Am J Pathol 2002; 160: 14051423.
  • 4
    Makris A, Thornton C, Thompson J et al . Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int 2007: Epub Mar 21.
  • 5
    He H, Venema VJ, Gu X, Venema RC, Marrero MB, Caldwell RB. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through Flk-1/KDR activation of c-Src. J Biol Chem 1999; 274: 2513025135.
  • 6
    Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct 2001; 26: 2535.
  • 7
    Levine R., Maynard S, Qian C et al . Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672683.
  • 8
    Brown MA, Hague WM, Higgins J et al . Australasian Society for the Study of Hypertension in Pregnancy. The detection, investigation and management of hypertension in pregnancy: Executive summary. Aust N Z J Obstet Gynaecol 2000; 40: 133138.
  • 9
    Roberts J. Pregnancy-related hypertension. In: CreasyR, ResnickR, eds. Maternal-Fetal Medicine, 4th edn. Philadelphia, PA: W.B. Saunders Company, 1999; 833871.
  • 10
    Chesley L, Williams L. Renal glomerular and tubular function in relation to the hyperuricaemia of preeclampsia and eclampsia. Am J Obstet Gynecol 1945; 50: 367375.
  • 11
    Boyle J, Campbell S, Duncan A. Serum uric acid levels in normal pregnancy with observations on the renal excretion of urate in pregnancy. J Clin Pathol 1966; 19: 501503.
  • 12
    Many A, Hubel C, Roberts J. Hyperuricaemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol 1996; 174: 288291.
  • 13
    Shuster E, Weppelman B. Plasma urate measurements and fetal outcome in preeclampsia. Gynecol Obstet Invest 1981; 12: 162.
  • 14
    Acien P, Lloret G, Lloret M. Perinatal morbidity and mortality in pregnancy hypertensive disorders: Prognostic value of the clinical and laboratory findings. Int J Gynaecol Obstet 1990; 32: 229235.
  • 15
    Redman C, Beilin L, Bonnar J, Wilkinson R. Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet 1976; 1: 13701373.
  • 16
    Sagen N, Kjell H, Nilsen S. Serum urate as a predictor of fetal outcome in severe preeclampsia. Acta Obstet Gynecol Scand 1984; 63: 7175.
  • 17
    Lim K, Friedman S, Ecker J, Kao L, Kilpatrick S. The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy. Am J Obstet Gynecol 1998; 178: 10671071.
  • 18
    Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1S22.
  • 19
    Aquilina J, Barnett A, Thompson O, Harrington K. Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia. Am J Obstet Gynecol 1999; 181: 131136.
  • 20
    Sebire N, Roberts L, Noble P, Wallace E, Nicolaides KH. Raised maternal serum inhibin A concentration at 10–14 weeks of gestation is associated with preeclampsia. Br J Obstet Gynaecol 2000; 107: 795797.
  • 21
    Lambert-Messerlain G, Silver H, Petraglia F et al . Second trimester levels of maternal serum human chorionic gonadotrophin and inhibin A as predictors of preeclampsia in the third trimester of pregnancy. J Soc Gynecol Invest 2000; 7: 170174.
  • 22
    Wald N, Morris J. Multiple marker second trimester serum screening for preeclampsia. J Med Screen 2001; 8: 6568.
  • 23
    Lee L, Sheu B, Shau W et al . Mid-trimester β-hCG levels incorporated in a multifactorial model for prediction of severe preeclampsia. Prenat Diagn 2000; 20: 738743.
  • 24
    Aquilina J, Thompson O, Thilaganathan B, Harrington K. Improved early prediction of preeclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler. Ultrasound Obstet Gynecol 2001; 17: 477484.
  • 25
    Anim-Nyame N, Sooranna S, Steer P, Johnson MR. Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and preeclampsia. Hum Reprod 2000; 15: 20332036.
  • 26
    Anim-Nyame N, Hills FA, Sooranna SR, Steer PJ, Johnson MR. A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia. Hum Reprod 2000; 15: 22152219.
  • 27
    Ballegeer V, Spitz B, Kieckens L, Moreau H, Van Assche A, Collen D. Predictive value of increased plasma levels of fibronectin in gestational hypertension. Am J Obstet Gynecol 1989; 161: 432436.
  • 28
    Lazarchik J, Stubbs T, Romein L, Van Dorsten JP, Loadholt CB. Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic. Am J Obstet Gynecol 1986; 154: 10501052.
  • 29
    Chavarria M, Lara-Gonzalez L, Gonzalez-Gleason A, Sojo I, Reyes A. Maternal plasma cellular fibronectin concentrations in normal and preeclamptic pregnancies: A longitudinal study for early prediction of preeclampsia. Am J Obstet Gynecol 2002; 187: 595601.
  • 30
    Parretti E, Lapolla A, Dalfra M et al . Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes. Hypertension 2006; 47: 449453.
  • 31
    Koga K, Osuga Y, Yoshino O et al . Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 2003; 88: 23482351.
  • 32
    Chaiworapongsa T, Romero R, Espinoza J et al . Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Am J Obstet Gynecol 2004; 190: 15411547.
  • 33
    Hertig A, Berkane N, Lefevre G et al . Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem 2004; 50: 17021703.
  • 34
    Levine R, Maynard S, Qian C et al . Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672683.